Compounds > erlotinib hydrochloride
Page last updated: 2024-09-05

erlotinib hydrochloride and bms 777607

erlotinib hydrochloride has been researched along with bms 777607 in 1 studies

Compound Research Comparison

Studies
(erlotinib hydrochloride)		Trials
(erlotinib hydrochloride)		Recent Studies (post-2010)
(erlotinib hydrochloride)		Studies
(bms 777607)		Trials
(bms 777607)		Recent Studies (post-2010) (bms 777607)
4,3537863,03352049

Protein Interaction Comparison

ProteinTaxonomyerlotinib hydrochloride (IC50)bms 777607 (IC50)
High affinity nerve growth factor receptorHomo sapiens (human)0.29
Tyrosine-protein kinase LckHomo sapiens (human)0.12
Proto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)0.594
Hepatocyte growth factor receptorHomo sapiens (human)0.0343
Mast/stem cell growth factor receptor KitHomo sapiens (human)0.144
Platelet-derived growth factor receptor alphaHomo sapiens (human)0.028
cAMP-dependent protein kinase catalytic subunit alphaHomo sapiens (human)0.55
Tyrosine-protein kinase receptor UFOHomo sapiens (human)0.0319
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.1635
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)0.0167
Macrophage-stimulating protein receptorHomo sapiens (human)0.0389
Tyrosine-protein kinase receptor TYRO3Homo sapiens (human)0.0529
Tyrosine-protein kinase MerHomo sapiens (human)0.014
BDNF/NT-3 growth factors receptorHomo sapiens (human)0.19
Aurora kinase BHomo sapiens (human)0.078

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Axel, U; Baska, F; Greff, Z; Gyulavári, P; Ibolya, K; Kéri, G; Orfi, L; Peták, I; Szántai, KC; Szokol, B; Vantus, T; Zoltán, O1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and bms 777607

ArticleYear
[Development and biochemical characterization of EGFR/c-Met dual inhibitors].
    Acta pharmaceutica Hungarica, 2013, Volume: 83, Issue:4

    Topics: Afatinib; Aminopyridines; Anilides; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Line, Tumor; Computer Simulation; Crizotinib; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Humans; Imidazoles; Lapatinib; Lung Neoplasms; Molecular Structure; Protein Kinase Inhibitors; Protein Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-met; Pyrazines; Pyrazoles; Pyridines; Pyridones; Quinazolines; Quinolines

2013